
Senior Scientist, Clinical Research
Merck
Summary
The Early Clinical Scientist (ECS) coordinates the design, planning and execution of early phase clinical trials with the Clinical Director, and internal/external team members. Oversees trials within and/or across program(s)/therapeutic areas and ensures excellence in execution/compliance to support study objectives and data validity.
Job description
Responsibilities
- Manages internal/external team performance to achieve project objectives and resolves project performance issues if they arise.
- Ensures appropriate clinical safety assessment and risk management of compounds.
- Conducts real-time oversight of ongoing trials to identify and mitigate patient, study design, data or study conduct issues.
- Reviews and interprets clinical trial data.
- May conduct on-site study monitoring, including site training & supervision of complex, novel endpoint/biomarker collection processes.
- Applies thorough knowledge of GCP, ICH guidelines and regulatory requirements for clinical development.
- Represents Early-Stage Development on cross-functional teams to develop and/or improve internal job aids/SOP/clinical development procedures.
- Identifies and communicates best practices within the organization and promotes departmental adaptation of new procedures.
Technical Writing & Communications
- Co-authors clinical sections of protocols, clinical investigator brochures, clinical study reports, WMA/CTD subsections, and regulatory agency update and safety reports, as well as clinical development plans, publications, and abstracts.
- Ensures documents are completed in accordance with applicable standards.
- Develops study operational documents with input from team members (e.g. site monitoring plan, study operations manual, informed consent).
Project Management
- Manages trial and program projects including team activities, provides risk assessment and contingency planning, under accelerated timelines.
- Familiar with early drug development processes, building knowledge and skills to effectively manage additional processes/procedures.
Requirements
- Degree in Life Sciences: Bachelor's degree and ≥6 years related experience, OR Master's degree and ≥4 years related experience, OR PhD or doctorate with ≥2 years related experience
- Experience in an operational clinical scientist or study manager role in clinical research at a pharmaceutical or biotech company
- Understanding of clinical research development process from program planning to regulatory submission
- Able to quickly develop a working scientific knowledge of different therapeutic areas
- Ability to manage complex operations and projects under accelerated timelines
- Scientific, medical and/or safety writing and reporting (at least one is required)
- Ability to partner effectively with internal and external teams to achieve results
- Strong team collaboration, leadership, communication (written & verbal), issue identification and resolution skills
- Knowledge of GCP, ICH guidelines and regulatory requirements
- Preferred: Global Phase I subject and patient trials, safety reporting, and regulatory WMA submission experience
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation Days
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.